We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$2.85B
AUM Growth
+$169M
Cap. Flow
+$16.4M
Cap. Flow %
0.58%
Top 10 Hldgs %
65.16%
Holding
451
New
10
Increased
153
Reduced
16
Closed
14

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$5.11M
2
LMND icon
Lemonade
LMND
+$4.4M
3
TTD icon
Trade Desk
TTD
+$3.52M
4
BSX icon
Boston Scientific
BSX
+$2.93M
5
TRP icon
TC Energy
TRP
+$2.69M

Top Sells

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$25M
2
LLY icon
Eli Lilly
LLY
+$4.8M
3
STAA icon
STAAR Surgical
STAA
+$1.43M
4
BPMC
Blueprint Medicines
BPMC
+$1.12M
5
TCP
TC Pipelines LP
TCP
+$337K

Sector Composition

Rank Sector Weight
1 Healthcare 46.71%
2 Consumer Discretionary 8.55%
3 Technology 8.03%
4 Communication Services 7.66%
5 Financials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAB icon
426
Wabtec
WAB
$49.4B
$2K ﹤0.01%
21
– –
NBRV
427
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2K ﹤0.01%
40
– –
FLR icon
428
Fluor
FLR
$6.99B
$1K ﹤0.01%
45
– –
ITRM
429
DELISTED
Iterum Therapeutics
ITRM
$1K ﹤0.01%
48
– –
MKC icon
430
McCormick & Company Non-Voting
MKC
$13.7B
$1K ﹤0.01%
12
– –
WFC icon
431
Wells Fargo
WFC
$258B
$1K ﹤0.01%
29
– –
BPMC
432
DELISTED
Blueprint Medicines
BPMC
– –
-10,000
Closed -$1.12M
DKNG icon
433
DraftKings
DKNG
$11.8B
– –
-537,363
Closed -$25M
DNTH icon
434
Dianthus Therapeutics
DNTH
$6.16B
– –
-1,750
Closed -$220K
DXC icon
435
DXC Technology
DXC
$1.82B
$0 ﹤0.01%
13
– –
FCX icon
436
Freeport-McMoran
FCX
$91.2B
$0 ﹤0.01%
4
– –
FICO icon
437
Fair Isaac
FICO
$24.6B
– –
-200
Closed -$102K
FTNT icon
438
Fortinet
FTNT
$113B
– –
-5
Closed –
GMAB icon
439
Genmab
GMAB
$17.6B
– –
-200
Closed -$8K
NVT icon
440
nVent Electric
NVT
$23.4B
$0 ﹤0.01%
1
– –
PEN icon
441
Penumbra
PEN
$12.6B
– –
-1
Closed –
PGR icon
442
Progressive
PGR
$124B
– –
-1
Closed –
PINS icon
443
Pinterest
PINS
$13.7B
– –
-1
Closed –
QDEL icon
444
QuidelOrtho
QDEL
$1.13B
– –
-150
Closed -$27K
REZI icon
445
Resideo Technologies
REZI
$5.26B
$0 ﹤0.01%
16
– –
STAA icon
446
STAAR Surgical
STAA
$1.21B
– –
-18,000
Closed -$1.43M
PRSP
447
DELISTED
Perspecta Inc. Common Stock
PRSP
$0 ﹤0.01%
6
– –
CXO
448
DELISTED
CONCHO RESOURCES INC.
CXO
– –
-912
Closed -$53K
BMCH
449
DELISTED
BMC Stock Holdings, Inc
BMCH
– –
-3,300
Closed -$177K
HZNP
450
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-200
Closed -$15K
15 16 17
18
19

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return

Bollard Group's Q1 2021 Portfolio in Review

As of Q1 2021, Bollard Group held 451 positions worth $2.85B, up 6.3% from $2.69B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Bollard Group's Q1 2021 filing shows 10 new, 153 increased, 16 reduced and 14 closed positions. Its largest new stake was Lemonade: 34,100 shares worth $3.18M. The largest sale was DraftKings, an estimated $25M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bollard Group's largest Q1 2021 buy was Lemonade: 34,100 shares worth $3.18M.
  • Bollard Group added most to Gartner in Q1 2021, an estimated $5.11M increase.
  • Bollard Group's biggest Q1 2021 reduction was Eli Lilly, cutting an estimated $4.8M.
  • Bollard Group fully exited DraftKings in Q1 2021, selling an estimated $25M.
  • Bollard Group's ten largest holdings make up 65% of its $2.85B portfolio in Q1 2021.
  • Bollard Group opened 10 new positions and closed 14 in Q1 2021.
  • Bollard Group's portfolio value rose 6.3% quarter-over-quarter to $2.85B.

Based on Bollard Group's 13F filing for Q1 2021, filed 11 May 2021.